Literature DB >> 29389393

Not all vascular smooth muscle cell exosomes calcify equally in chronic kidney disease.

Adriana Dusso1, Maria Isabel Colombo2, Catherine M Shanahan3.   

Abstract

Prevention of medial calcification in patients with chronic kidney disease requires the maintenance of vascular smooth muscle cell fitness. To preserve viability under chronic kidney disease-induced stress, vascular smooth muscle cells increase exosome formation and release, but the result is aggravated pathological calcification. Now Chen et al. report that microvesicles from calcifying vascular smooth muscle cells may propagate procalcifying signals to normal vascular smooth muscle cells. To help design effective strategies to impair procalcifying cell-to-cell communication, this commentary updates the current understanding of the main regulators of microvesicle/exosome biogenesis and secretion.
Copyright © 2017 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29389393     DOI: 10.1016/j.kint.2017.08.036

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  4 in total

Review 1.  What can urinary exosomes tell us?

Authors:  Rui Vitorino; Rita Ferreira; Sofia Guedes; Francisco Amado; Visith Thongboonkerd
Journal:  Cell Mol Life Sci       Date:  2021-01-28       Impact factor: 9.261

Review 2.  New insight into the role of extracellular vesicles in kidney disease.

Authors:  Lin-Li Lv; Ye Feng; Tao-Tao Tang; Bi-Cheng Liu
Journal:  J Cell Mol Med       Date:  2018-12-25       Impact factor: 5.310

Review 3.  Effects of Chronic Kidney Disease and Uremic Toxins on Extracellular Vesicle Biology.

Authors:  Linda Yaker; Saïd Kamel; Jérôme Ausseil; Agnès Boullier
Journal:  Toxins (Basel)       Date:  2020-12-21       Impact factor: 4.546

4.  Calciprotein Particles: Balancing Mineral Homeostasis and Vascular Pathology.

Authors:  Anton G Kutikhin; Lian Feenstra; Alexander E Kostyunin; Arseniy E Yuzhalin; Jan-Luuk Hillebrands; Guido Krenning
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-11       Impact factor: 8.311

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.